| Nikki Rose Karnes, SLP | |
|
7401 Beaufont Springs Dr Ste 205, North Chesterfield, VA 23225-5504 | |
| (804) 272-0114 | |
| Not Available |
| Full Name | Nikki Rose Karnes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7401 Beaufont Springs Dr Ste 205, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306628607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202004081 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nikki Rose Karnes, SLP 7401 Beaufont Springs Dr Ste 205, North Chesterfield, VA 23225-5504 Ph: (804) 272-0114 | Nikki Rose Karnes, SLP 7401 Beaufont Springs Dr Ste 205, North Chesterfield, VA 23225-5504 Ph: (804) 272-0114 |
News Archive
Chagas disease, a historically neglected tropical disease that the WHO estimates affects about 10 million people worldwide, is drawing increased attention as infection by the parasite spreads from Latin America to developed countries, such as Spain and the United States, Science reports.
Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.
The Centre for Disease Prevention and Control (CDC) has warned that as restaurants are closed due to social distancing and lockdowns owing to the COVID-19 pandemic, rats are resurfacing en masse. The CDC warns that these rats are becoming aggressive as they are deprived of their usual source of food.
Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).
Australian drug development company CBio Limited today announced the achievement of a recruitment milestone in its clinical trial of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis.
› Verified 8 days ago
Paige Sapp, M,S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Twinridge Ln Ste A, North Chesterfield, VA 23235 Phone: 804-323-9060 | |
Chesterfield Speech-language Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9311 Southport Dr, North Chesterfield, VA 23235 Phone: 804-677-6966 | |
U-speak, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 Branchway Rd Ste 108, North Chesterfield, VA 23236 Phone: 804-399-5815 | |
Miss Rebecca Hayden Saur, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-2936 | |
Miss Carrie Lynn Willis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-2936 | |
Jennifer Znotens, M,A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7401 Beaufont Spring Dr, Suite 205, North Chesterfield, VA 23225 Phone: 804-272-0114 Fax: 804-272-1125 |